Repository logo
 

Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence

dc.contributor.authorSleath, Betsy
dc.contributor.authorCarpenter, Delesha M
dc.contributor.authorBlalock, Susan J
dc.contributor.authorDavis, Scott A
dc.contributor.authorHickson, Ryan P
dc.contributor.authorLee, Charles
dc.contributor.authorFerreri, Stefanie P
dc.contributor.authorScott, Jennifer E
dc.contributor.authorRodebaugh, Lisa B
dc.contributor.authorCummings, Doyle M.
dc.date.accessioned2020-05-05T16:26:19Z
dc.date.available2020-05-05T16:26:19Z
dc.date.issued2016-06-07
dc.description.abstractBackground: Although there are several different general diabetes self-efficacy scales, there is a need to develop a self-efficacy scale that providers can use to assess patient’s self-efficacy regarding medication use. The purpose of this study was to: 1) develop a new diabetes medication self-efficacy scale and 2) examine how diabetes medication self-efficacy is associated with patient-reported problems in using diabetes medications and self-reported adherence. Patients and methods: Adult English-speaking patients with type 2 diabetes were recruited from a family medicine clinic and a pharmacy in Eastern North Carolina, USA. The patients were eligible if they reported being nonadherent to their diabetes medicines on a visual analog scale. Multivariable regression was used to examine the relationship between self-efficacy and the number of reported diabetes medication problems and adherence. Results: The diabetes medication self-efficacy scale had strong reliability (Cronbach’s alpha =0.86). Among a sample (N=51) of mostly African-American female patients, diabetes medication problems were common (6.1±3.1) and a greater number of diabetes medications were associated with lower medication adherence (odds ratio: 0.35; 95% confidence interval: 0.13, 0.89). Higher medication self-efficacy was significantly related to medication adherence (odds ratio: 1.17; 95% confidence interval: 1.05, 1.30) and inversely related to the number of self-reported medication problems (β=-0.13; P=0.006). Conclusion: Higher diabetes medication self-efficacy was associated with fewer patient- reported medication problems and better medication adherence. Assessing medication-specific self-efficacy may help to identify medication-related problems that providers can help the patients address, potentially improving adherence and patient outcomes. Keywords: diabetes, adherence, self-efficacy, literacyen_US
dc.identifier.doi10.2147/PPA.S101349
dc.identifier.urihttp://hdl.handle.net/10342/8500
dc.titleDevelopment of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherenceen_US
dc.typeArticleen_US
ecu.journal.namePatient Preference and Adherenceen_US
ecu.journal.pages1003–1010en_US
ecu.journal.volume10en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ppa-10-1003.pdf
Size:
317.42 KB
Format:
Adobe Portable Document Format
Description:

Collections